ImageneBio, Inc. (NasdaqCM: IMA)
Health Care · Biotechnology · US
$4.04
-4.72% today · -46.7% 1Y
ImageneBio, Inc. (NasdaqCM: IMA) operates in the Biotechnology industry within the Health Care sector. The company is valued at $45.86M and employs 18 people.
Over the last twelve months the share price has lost 46.7%, trading between 3.90 and 9.10.
Tweenvest scores ImageneBio, Inc. across four factors: quality 46/100, value 21/100. Its strongest factor is quality.
IMA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $45.86M
- Revenue (TTM)
- $0.00
- P/E
- —
- EPS
- -4.81
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $9.10
- 52-week low
- $3.90
- Avg volume (3M)
- —
- Shares outstanding
- 11.35M
- Employees
- 18
- Next earnings
- —
About ImageneBio, Inc.
ImageneBio, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for patients with immunological, autoimmune and inflammatory diseases. Its lead product candidate includes IMG-007, a non-depleting anti-OX40 monoclonal antibody that binds to OX40 receptor on activated T cells to block receptor binding to OX40 ligand which is in Phase 1b/2a clinical trial. The company was formerly known as Ikena Oncology, Inc. and changed its name to ImageneBio, Inc. in July 2025. ImageneBio, Inc. is headquartered in San Diego, California.
- ISIN
- US45175G2075
- Listed since
- Feb 27, 1998
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Solasia Pharma K.K.TSE: 4597 | $46.69M | ¥27.00 | -6.90% |
| OncoTherapy Science, Inc.TSE: 4564 | $46.54M | ¥18.00 | -5.26% |
| Apollomics, Inc.NasdaqCM: APLM | $46.34M | $21.10 | -1.86% |
| Prescient Therapeutics LimitedASX: PTX | $46.16M | AU$0.06 | -12.12% |
| Harvard Apparatus Regenerative Technology Inc.OTCPK: HRGN | $45.23M | $2.23 | -3.04% |
| Mereo BioPharma Group plcNasdaqCM: MREO | $44.98M | $0.28 | -1.98% |
| GenMont Biotech IncorporationTWSE: 3164 | $44.54M | NT$16.80 | -0.88% |
| Clene Inc.NasdaqCM: CLNN | $44.06M | $3.10 | -19.69% |
Figures last refreshed Oct 18, 2026.